

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.42110972 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.29104777 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.15704719 |
| 4 | complement activation, classical pathway (GO:0006958) | 5.99163511 |
| 5 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.46615239 |
| 6 | B cell receptor signaling pathway (GO:0050853) | 5.46217414 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41747935 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 5.39845678 |
| 9 | positive regulation of respiratory burst (GO:0060267) | 5.00720289 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.00389780 |
| 11 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.95457933 |
| 12 | detection of bacterium (GO:0016045) | 4.76230581 |
| 13 | complement activation (GO:0006956) | 4.70059920 |
| 14 | cellular response to type I interferon (GO:0071357) | 4.65062842 |
| 15 | type I interferon signaling pathway (GO:0060337) | 4.65062842 |
| 16 | response to type I interferon (GO:0034340) | 4.60385171 |
| 17 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.55909167 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.48380623 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48380623 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.48380623 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48380623 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48380623 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48380623 |
| 24 | negative regulation of cell killing (GO:0031342) | 4.45134133 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.45134133 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.44975010 |
| 27 | regulation of antigen processing and presentation (GO:0002577) | 4.43508146 |
| 28 | detection of other organism (GO:0098543) | 4.37182594 |
| 29 | B cell mediated immunity (GO:0019724) | 4.32299919 |
| 30 | B cell homeostasis (GO:0001782) | 4.14942436 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.98028439 |
| 32 | T cell costimulation (GO:0031295) | 3.95221921 |
| 33 | cellular response to interferon-gamma (GO:0071346) | 3.91214680 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 3.90058219 |
| 35 | lymphocyte costimulation (GO:0031294) | 3.89280578 |
| 36 | regulation of respiratory burst (GO:0060263) | 3.81230946 |
| 37 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.79901886 |
| 38 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.78454841 |
| 39 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.78454841 |
| 40 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.78454841 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.75941284 |
| 42 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.74536804 |
| 43 | humoral immune response (GO:0006959) | 3.72720124 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.69167346 |
| 45 | antimicrobial humoral response (GO:0019730) | 3.58153268 |
| 46 | antibacterial humoral response (GO:0019731) | 3.54528154 |
| 47 | glomerular filtration (GO:0003094) | 3.53415960 |
| 48 | response to interferon-gamma (GO:0034341) | 3.49516375 |
| 49 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.48837930 |
| 50 | positive thymic T cell selection (GO:0045059) | 3.47195199 |
| 51 | regulation of cellular extravasation (GO:0002691) | 3.46129727 |
| 52 | protein activation cascade (GO:0072376) | 3.45398298 |
| 53 | B cell proliferation (GO:0042100) | 3.39838166 |
| 54 | T-helper 1 type immune response (GO:0042088) | 3.38154433 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.31676210 |
| 56 | response to host immune response (GO:0052572) | 3.27810853 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.27810853 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.27376249 |
| 59 | angiotensin maturation (GO:0002003) | 3.25411529 |
| 60 | myeloid dendritic cell differentiation (GO:0043011) | 3.17072236 |
| 61 | T cell migration (GO:0072678) | 3.16035985 |
| 62 | positive regulation of interferon-alpha production (GO:0032727) | 3.14658683 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14000549 |
| 64 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.12932980 |
| 65 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.12396823 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 3.10941279 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 3.10074768 |
| 68 | renal filtration (GO:0097205) | 3.08335021 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 3.02171092 |
| 70 | negative thymic T cell selection (GO:0045060) | 3.01938674 |
| 71 | germinal center formation (GO:0002467) | 3.01344538 |
| 72 | detection of external biotic stimulus (GO:0098581) | 2.99975343 |
| 73 | response to host (GO:0075136) | 2.96489493 |
| 74 | response to host defenses (GO:0052200) | 2.96489493 |
| 75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96489493 |
| 76 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94861107 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93808565 |
| 78 | thymic T cell selection (GO:0045061) | 2.93222653 |
| 79 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.93185921 |
| 80 | production of molecular mediator of immune response (GO:0002440) | 2.92523936 |
| 81 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.91776430 |
| 82 | negative regulation of B cell proliferation (GO:0030889) | 2.90152091 |
| 83 | regulation of interferon-alpha production (GO:0032647) | 2.87337900 |
| 84 | cytidine metabolic process (GO:0046087) | 2.86098330 |
| 85 | cytidine catabolic process (GO:0006216) | 2.86098330 |
| 86 | cytidine deamination (GO:0009972) | 2.86098330 |
| 87 | lymphocyte homeostasis (GO:0002260) | 2.84857759 |
| 88 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.83957441 |
| 89 | defense response to protozoan (GO:0042832) | 2.83900004 |
| 90 | regulation of B cell proliferation (GO:0030888) | 2.83015631 |
| 91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.81971808 |
| 92 | immune response-activating signal transduction (GO:0002757) | 2.81307529 |
| 93 | positive regulation of humoral immune response (GO:0002922) | 2.80032730 |
| 94 | positive regulation of Rap GTPase activity (GO:0032854) | 2.78123200 |
| 95 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.75524789 |
| 96 | peptide catabolic process (GO:0043171) | 2.73177498 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 2.72462643 |
| 98 | negative T cell selection (GO:0043383) | 2.70602782 |
| 99 | positive regulation of neutrophil migration (GO:1902624) | 2.70136649 |
| 100 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.70136649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.98501965 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.87948947 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.80924154 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.49398753 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.48654271 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.44998835 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.82947948 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.82375076 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.79706902 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.73988742 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68237884 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.66632213 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44138378 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.43190057 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43167265 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.36570655 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29764307 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25235685 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.24939219 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24059125 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23758260 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21872537 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.21790676 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.17450991 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16930897 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.16649480 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.05599251 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.97460700 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.97249726 |
| 30 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.96402864 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93033255 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89817684 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.82825508 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79587612 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78841956 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75519051 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69389861 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66496993 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64159584 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63029715 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57156544 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56600498 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56219187 |
| 44 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52480073 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49267334 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.47758384 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.47741733 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38549086 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35232230 |
| 50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33821501 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33103775 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32907438 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31827094 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31084890 |
| 55 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30334646 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28263398 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28150775 |
| 58 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26722712 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26408167 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24546285 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21948089 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21779841 |
| 63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19920889 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19592081 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18997474 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16018385 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14716858 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14706825 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14352108 |
| 70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11256870 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10965079 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08631844 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06695546 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06659207 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05697614 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04761051 |
| 77 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03570115 |
| 78 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02766879 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02396859 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02189885 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02157432 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01036837 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00220277 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98955727 |
| 85 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98926222 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98917347 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98180972 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96074699 |
| 89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95993443 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95709549 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95216028 |
| 92 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94544440 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93944650 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92575499 |
| 95 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91073647 |
| 96 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.90083677 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89475488 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87885282 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87099392 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86828119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.38402913 |
| 2 | MP0003303_peritoneal_inflammation | 3.93416692 |
| 3 | MP0000685_abnormal_immune_system | 3.86429156 |
| 4 | MP0001790_abnormal_immune_system | 3.74738885 |
| 5 | MP0005387_immune_system_phenotype | 3.74738885 |
| 6 | MP0005671_abnormal_response_to | 3.51758066 |
| 7 | MP0001800_abnormal_humoral_immune | 3.48744005 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.99036722 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.87135866 |
| 10 | MP0010155_abnormal_intestine_physiology | 2.80176904 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.73258339 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.71277422 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.65258802 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.65090859 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.53487312 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.53455142 |
| 17 | MP0002723_abnormal_immune_serum | 2.48270686 |
| 18 | MP0003436_decreased_susceptibility_to | 2.48207762 |
| 19 | MP0005025_abnormal_response_to | 2.45820861 |
| 20 | MP0009785_altered_susceptibility_to | 2.44352820 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.37705413 |
| 22 | MP0001819_abnormal_immune_cell | 2.36802772 |
| 23 | MP0003724_increased_susceptibility_to | 2.19605484 |
| 24 | MP0001873_stomach_inflammation | 2.11407364 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.09387540 |
| 26 | MP0003866_abnormal_defecation | 1.93823520 |
| 27 | MP0002398_abnormal_bone_marrow | 1.92925127 |
| 28 | MP0002419_abnormal_innate_immunity | 1.91398358 |
| 29 | MP0002006_tumorigenesis | 1.90345469 |
| 30 | MP0000716_abnormal_immune_system | 1.89413361 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.87887962 |
| 32 | MP0005360_urolithiasis | 1.85861164 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.84829361 |
| 34 | MP0005310_abnormal_salivary_gland | 1.81329888 |
| 35 | MP0005451_abnormal_body_composition | 1.73826918 |
| 36 | MP0001666_abnormal_nutrient_absorption | 1.70240417 |
| 37 | MP0003252_abnormal_bile_duct | 1.61995059 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.61566822 |
| 39 | MP0002429_abnormal_blood_cell | 1.55349429 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.53606288 |
| 41 | MP0004947_skin_inflammation | 1.52263394 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.51061139 |
| 43 | MP0000490_abnormal_crypts_of | 1.48050347 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.41583957 |
| 45 | MP0005166_decreased_susceptibility_to | 1.38784543 |
| 46 | MP0002722_abnormal_immune_system | 1.36067742 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.35600499 |
| 48 | MP0009840_abnormal_foam_cell | 1.29195303 |
| 49 | MP0001663_abnormal_digestive_system | 1.25980919 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.23378391 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.22742938 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 1.19907521 |
| 53 | MP0003045_fibrosis | 1.18784097 |
| 54 | MP0008469_abnormal_protein_level | 1.17932921 |
| 55 | MP0002405_respiratory_system_inflammati | 1.16432894 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.09991603 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.07360390 |
| 58 | MP0003868_abnormal_feces_composition | 1.07046602 |
| 59 | MP0003091_abnormal_cell_migration | 1.06429164 |
| 60 | MP0006082_CNS_inflammation | 1.01805643 |
| 61 | MP0002009_preneoplasia | 1.00724233 |
| 62 | MP0000477_abnormal_intestine_morphology | 0.98690912 |
| 63 | MP0000703_abnormal_thymus_morphology | 0.97943171 |
| 64 | MP0002396_abnormal_hematopoietic_system | 0.96634753 |
| 65 | MP0009379_abnormal_foot_pigmentation | 0.93912854 |
| 66 | MP0008260_abnormal_autophagy | 0.92547878 |
| 67 | MP0002998_abnormal_bone_remodeling | 0.92031400 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 0.89868012 |
| 69 | MP0009643_abnormal_urine_homeostasis | 0.88288035 |
| 70 | MP0000858_altered_metastatic_potential | 0.86296808 |
| 71 | MP0003075_altered_response_to | 0.85907994 |
| 72 | MP0002796_impaired_skin_barrier | 0.84299739 |
| 73 | MP0000609_abnormal_liver_physiology | 0.83282211 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.83017885 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 0.80393810 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.76607766 |
| 77 | MP0000249_abnormal_blood_vessel | 0.76224758 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.75977247 |
| 79 | MP0002933_joint_inflammation | 0.75474522 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74833488 |
| 81 | MP0008874_decreased_physiological_sensi | 0.72880682 |
| 82 | MP0004858_abnormal_nervous_system | 0.71977534 |
| 83 | MP0000604_amyloidosis | 0.71843111 |
| 84 | MP0000343_altered_response_to | 0.70964670 |
| 85 | MP0009764_decreased_sensitivity_to | 0.65868080 |
| 86 | MP0005332_abnormal_amino_acid | 0.64952568 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.64350428 |
| 88 | MP0001853_heart_inflammation | 0.64316800 |
| 89 | MP0005365_abnormal_bile_salt | 0.62394137 |
| 90 | MP0004510_myositis | 0.62136111 |
| 91 | MP0009763_increased_sensitivity_to | 0.62004535 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 0.61299168 |
| 93 | MP0003448_altered_tumor_morphology | 0.59843721 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.57354045 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.56404051 |
| 96 | MP0010307_abnormal_tumor_latency | 0.54216290 |
| 97 | MP0005275_abnormal_skin_tensile | 0.53068205 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52862008 |
| 99 | MP0008872_abnormal_physiological_respon | 0.52550621 |
| 100 | MP0009115_abnormal_fat_cell | 0.52515743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal stroma tumor (HP:0100723) | 6.76261152 |
| 2 | Agammaglobulinemia (HP:0004432) | 6.53000480 |
| 3 | Recurrent bronchitis (HP:0002837) | 5.92331519 |
| 4 | Recurrent sinusitis (HP:0011108) | 4.87183691 |
| 5 | Meningitis (HP:0001287) | 4.81125891 |
| 6 | IgM deficiency (HP:0002850) | 4.58505208 |
| 7 | Cellulitis (HP:0100658) | 4.52150351 |
| 8 | Vasculitis (HP:0002633) | 4.44549600 |
| 9 | Emphysema (HP:0002097) | 4.35863574 |
| 10 | IgA deficiency (HP:0002720) | 4.34246191 |
| 11 | Eczematoid dermatitis (HP:0000976) | 4.26483204 |
| 12 | Colitis (HP:0002583) | 4.20634581 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.14338661 |
| 14 | Lymphopenia (HP:0001888) | 3.96496388 |
| 15 | Recurrent viral infections (HP:0004429) | 3.90403609 |
| 16 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.88366147 |
| 17 | Chronic diarrhea (HP:0002028) | 3.88058346 |
| 18 | Chronic otitis media (HP:0000389) | 3.85711564 |
| 19 | Malnutrition (HP:0004395) | 3.60895021 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.54623260 |
| 21 | Recurrent pneumonia (HP:0006532) | 3.53389399 |
| 22 | Osteomyelitis (HP:0002754) | 3.52679888 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.46849930 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46632878 |
| 25 | Verrucae (HP:0200043) | 3.43814203 |
| 26 | Papilloma (HP:0012740) | 3.43814203 |
| 27 | Restrictive lung disease (HP:0002091) | 3.43718499 |
| 28 | Recurrent lower respiratory tract infections (HP:0002783) | 3.43502921 |
| 29 | Bronchitis (HP:0012387) | 3.41025469 |
| 30 | Increased IgE level (HP:0003212) | 3.38617200 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.34424224 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.26214989 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 3.13186008 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07561952 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07561952 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.05962115 |
| 37 | Spontaneous hematomas (HP:0007420) | 3.04806956 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.03735325 |
| 39 | Skin rash (HP:0000988) | 3.01786752 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.00791171 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.97926668 |
| 42 | Obstructive lung disease (HP:0006536) | 2.97926668 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.92660836 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.92264606 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.86299785 |
| 46 | Urticaria (HP:0001025) | 2.84472574 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.79977701 |
| 48 | B lymphocytopenia (HP:0010976) | 2.79371876 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.73343138 |
| 50 | Encephalitis (HP:0002383) | 2.68565497 |
| 51 | Recurrent skin infections (HP:0001581) | 2.66139310 |
| 52 | IgG deficiency (HP:0004315) | 2.64474136 |
| 53 | Abnormality of complement system (HP:0005339) | 2.61215064 |
| 54 | Glomerulonephritis (HP:0000099) | 2.60988477 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.57976933 |
| 56 | Hemoptysis (HP:0002105) | 2.57424112 |
| 57 | Sepsis (HP:0100806) | 2.55790400 |
| 58 | Chronic sinusitis (HP:0011109) | 2.50684942 |
| 59 | Recurrent otitis media (HP:0000403) | 2.47602686 |
| 60 | Chest pain (HP:0100749) | 2.45711025 |
| 61 | Abnormality of the prostate (HP:0008775) | 2.45263066 |
| 62 | Nasal polyposis (HP:0100582) | 2.45041250 |
| 63 | Skin ulcer (HP:0200042) | 2.44134384 |
| 64 | Abnormality of T cells (HP:0002843) | 2.43733343 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43039422 |
| 66 | Lymphoma (HP:0002665) | 2.39786258 |
| 67 | Premature loss of primary teeth (HP:0006323) | 2.38212770 |
| 68 | Increased IgM level (HP:0003496) | 2.36834196 |
| 69 | Villous atrophy (HP:0011473) | 2.35109026 |
| 70 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.35109026 |
| 71 | Complement deficiency (HP:0004431) | 2.33805461 |
| 72 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.33083833 |
| 73 | Hemorrhage of the eye (HP:0011885) | 2.29342498 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.29069216 |
| 75 | Hypertensive crisis (HP:0100735) | 2.26771322 |
| 76 | Orchitis (HP:0100796) | 2.22594700 |
| 77 | Xerostomia (HP:0000217) | 2.20275042 |
| 78 | Arthralgia (HP:0002829) | 2.17595717 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.13079320 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.12482608 |
| 81 | Retrobulbar optic neuritis (HP:0100654) | 2.10378737 |
| 82 | Optic neuritis (HP:0100653) | 2.10378737 |
| 83 | Gingivitis (HP:0000230) | 2.07792475 |
| 84 | Nephritis (HP:0000123) | 2.06549717 |
| 85 | Myositis (HP:0100614) | 2.01937656 |
| 86 | Pulmonary embolism (HP:0002204) | 2.00263243 |
| 87 | Leukopenia (HP:0001882) | 1.95709237 |
| 88 | Viral hepatitis (HP:0006562) | 1.94123129 |
| 89 | Gangrene (HP:0100758) | 1.90787516 |
| 90 | Acrocyanosis (HP:0001063) | 1.90620285 |
| 91 | Petechiae (HP:0000967) | 1.88893543 |
| 92 | Metabolic alkalosis (HP:0200114) | 1.87375728 |
| 93 | Abnormal tarsal ossification (HP:0008369) | 1.85412621 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 1.82559097 |
| 95 | Pulmonary fibrosis (HP:0002206) | 1.82251764 |
| 96 | Alkalosis (HP:0001948) | 1.81085403 |
| 97 | Abnormality of T cell number (HP:0011839) | 1.79099333 |
| 98 | Purpura (HP:0000979) | 1.75929853 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 1.74555027 |
| 100 | Hepatitis (HP:0012115) | 1.73518375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.43729201 |
| 2 | MAP4K1 | 5.02477275 |
| 3 | PRPF4B | 4.45702216 |
| 4 | ERN1 | 4.08310225 |
| 5 | FGFR4 | 3.21773350 |
| 6 | TYK2 | 2.88950871 |
| 7 | MAP3K14 | 2.22125941 |
| 8 | BLK | 2.16504450 |
| 9 | MAP3K10 | 2.13169538 |
| 10 | KIT | 2.10080492 |
| 11 | CSF1R | 2.09255115 |
| 12 | JAK1 | 2.05801063 |
| 13 | IKBKE | 2.01898295 |
| 14 | IRAK4 | 2.00925536 |
| 15 | MAP3K13 | 2.00700184 |
| 16 | NEK9 | 1.91978938 |
| 17 | SYK | 1.91199299 |
| 18 | JAK3 | 1.75931701 |
| 19 | CDK19 | 1.75402483 |
| 20 | FGFR3 | 1.71969960 |
| 21 | TBK1 | 1.57514329 |
| 22 | EIF2AK3 | 1.50764225 |
| 23 | STK24 | 1.47746678 |
| 24 | BMPR2 | 1.46683357 |
| 25 | SMG1 | 1.44657547 |
| 26 | TRIB3 | 1.42229556 |
| 27 | SIK3 | 1.33262181 |
| 28 | CDC42BPA | 1.29747781 |
| 29 | MATK | 1.28446980 |
| 30 | BTK | 1.25954259 |
| 31 | LYN | 1.25931011 |
| 32 | CSK | 1.20725412 |
| 33 | EPHA3 | 1.13240720 |
| 34 | TESK2 | 1.10767329 |
| 35 | MAPK11 | 1.06903534 |
| 36 | PASK | 1.00866295 |
| 37 | ARAF | 1.00730336 |
| 38 | JAK2 | 0.98795784 |
| 39 | TAOK2 | 0.92622084 |
| 40 | MST1R | 0.90771811 |
| 41 | PRKCQ | 0.90689677 |
| 42 | IKBKB | 0.88972835 |
| 43 | DDR2 | 0.88120597 |
| 44 | ACVR1B | 0.87684674 |
| 45 | KSR2 | 0.85193543 |
| 46 | PDK1 | 0.84573135 |
| 47 | EPHB1 | 0.84185447 |
| 48 | SIK2 | 0.83782439 |
| 49 | LRRK2 | 0.83655950 |
| 50 | FGR | 0.81421789 |
| 51 | MAP3K9 | 0.79368496 |
| 52 | MAP3K1 | 0.78528458 |
| 53 | PDPK1 | 0.78168893 |
| 54 | NME2 | 0.76492100 |
| 55 | TXK | 0.75999901 |
| 56 | IRAK1 | 0.74032828 |
| 57 | HCK | 0.72757300 |
| 58 | LCK | 0.71933666 |
| 59 | PRKG2 | 0.70097936 |
| 60 | EEF2K | 0.69755009 |
| 61 | BRAF | 0.64944275 |
| 62 | GRK6 | 0.63380538 |
| 63 | ALK | 0.61439729 |
| 64 | MAPK7 | 0.60394041 |
| 65 | MAP3K8 | 0.59370805 |
| 66 | CDK4 | 0.57699874 |
| 67 | KDR | 0.57368168 |
| 68 | IRAK3 | 0.56772752 |
| 69 | RIPK1 | 0.55255126 |
| 70 | MAP2K2 | 0.51478664 |
| 71 | ZAP70 | 0.46651955 |
| 72 | MAPKAPK2 | 0.45649522 |
| 73 | MAP3K11 | 0.45010922 |
| 74 | STK10 | 0.43944657 |
| 75 | FYN | 0.43831448 |
| 76 | MAPK12 | 0.42577504 |
| 77 | TEC | 0.42534004 |
| 78 | MAPK4 | 0.42519955 |
| 79 | MST4 | 0.41698171 |
| 80 | SIK1 | 0.41141619 |
| 81 | PRKCI | 0.40598983 |
| 82 | TNK2 | 0.39929528 |
| 83 | YES1 | 0.39490374 |
| 84 | ITK | 0.39041639 |
| 85 | PRKCD | 0.37912185 |
| 86 | PTK6 | 0.36776044 |
| 87 | HIPK2 | 0.36395804 |
| 88 | PRKCH | 0.36243834 |
| 89 | PRKD2 | 0.34055363 |
| 90 | CDK12 | 0.32060294 |
| 91 | MELK | 0.31558667 |
| 92 | PIM1 | 0.30899030 |
| 93 | OXSR1 | 0.30601681 |
| 94 | FES | 0.29563452 |
| 95 | SCYL2 | 0.28714817 |
| 96 | INSR | 0.28348697 |
| 97 | CDK9 | 0.27869856 |
| 98 | TAOK1 | 0.27337455 |
| 99 | CHUK | 0.27312611 |
| 100 | NLK | 0.26369333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.67594035 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.64077409 |
| 3 | Asthma_Homo sapiens_hsa05310 | 4.59208223 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.43028307 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.15225961 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.61106565 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.12407463 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.09088106 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.78501064 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.75572491 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75129841 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.62775475 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.56837883 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.94845191 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 1.76102212 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67832354 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63052357 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.40596476 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39060667 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32037681 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.20920865 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.19682965 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11943327 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09978923 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08343579 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06055527 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05338501 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99729778 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98568133 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97438132 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93948529 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 0.91009848 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87844145 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87532660 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 0.85437858 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78030597 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 0.72577328 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 0.70909071 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66474051 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66317969 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64773614 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.63979511 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61663106 |
| 44 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60987628 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60923585 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60358050 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57355633 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54559239 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50517037 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49709691 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49061427 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46277914 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45663228 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.45077228 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44205216 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43011303 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42672105 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40736927 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39550455 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36846583 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36248141 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35173121 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33758186 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32164968 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30683336 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30449831 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29780455 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29288669 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.29052667 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28717407 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28601567 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27720102 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27074111 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26484812 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25472405 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24122788 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.23355472 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22480359 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22432007 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22382958 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21331723 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.21288289 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.21186603 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.20163844 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20116564 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.19530288 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18422886 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18071413 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17488755 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.16597742 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.15410712 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.14706093 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14589671 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.13987885 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13469993 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.12364087 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.12136510 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.12077529 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.11254710 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.11110817 |

